A recent investigation has brought to light the alarming rates of undiagnosed placenta accreta spectrum (PAS) among pregnant women, with advocates urging immediate reforms in healthcare practices. This condition, which can lead to severe complications during childbirth, highlights the critical need for improved antenatal screening and training within maternity services.
The Impact of Undiagnosed Conditions
Chloe Robinson’s harrowing experience serves as a poignant example of the life-threatening implications of PAS. In July 2024, during an emergency caesarean at Burnley Hospital, she lost over five litres of blood—a shocking figure that underscores the severity of her condition, which had gone undiagnosed. At the age of 32, Robinson was completely unaware that she was dealing with PAS, a serious complication where the placenta adheres too deeply to the uterine wall, complicating its removal after delivery.
The urgency of her situation escalated rapidly, plunging medical staff into a state of crisis as they scrambled to save both Robinson and her newborn daughter, Poppy. Though they succeeded, Robinson reflects on the emotional turmoil of her experience, noting that an earlier diagnosis could have alleviated some of her trauma and allowed her to prepare for the potential challenges ahead.
The Statistics Behind the Condition
Research conducted by Action for Accreta reveals that a staggering 61 per cent of women with PAS remain undiagnosed until after delivery, while 64 per cent require emergency surgical intervention. The condition affects approximately one in every 272 pregnancies, making it a significant concern within maternal healthcare.
Factors contributing to the risk of developing PAS include previous caesarean sections, advanced maternal age, and conditions such as placenta praevia. Despite these known risk factors, the current ultrasound technology often fails to accurately detect PAS, leading many women to enter labour unaware of their condition.
Calls for Systemic Change in Maternity Care
In light of these findings, survivors like Robinson are advocating for enhanced training and awareness regarding PAS among maternity staff. They argue that improved screening protocols could facilitate earlier diagnoses, allowing healthcare professionals to better prepare for potential complications such as significant blood loss during delivery.
Following Robinson’s ordeal, East Lancashire Hospitals NHS Trust pledged to revise its guidelines to ensure that at-risk women are closely monitored and referred to specialists for proactive screening. Chief Nurse Pete Murphy acknowledged the necessity for a coordinated approach among medical teams to enhance the detection and management of PAS.
Dr Chineze Otigbah, an obstetrician and expert in fetal medicine, emphasised that while the condition itself is not fatal, the complications arising from its mismanagement can be catastrophic. She reiterated the importance of early intervention, particularly for women with known risk factors.
Personal Stories of Struggle and Survival
The plight of mothers like Kimberely Littler and Katie Buckingham further illustrates the pressing need for systemic improvements. Littler, who underwent a hysterectomy after a prolonged ordeal following the birth of her son Eli, highlighted the importance of clear communication and training among healthcare providers. She was only diagnosed with PAS after advocating for herself during an ultrasound, a situation that could have had dire consequences had she not spoken up.
Buckingham’s experience was equally distressing. Despite being suspected of having PAS, her condition went unconfirmed until after she experienced a series of complications, including a secondary haemorrhage and a retained placenta. She articulated the need for comprehensive care and better diagnostic practices to prevent unnecessary trauma for mothers and their families.
Moving Forward with Enhanced Guidelines
In response to these incidents, the Royal College of Obstetricians and Gynaecologists (RCOG) is set to update its guidelines regarding PAS and placenta praevia, reflecting the latest evidence and emphasising the necessity for early detection and appropriate management.
Donald Peebles, NHS England’s national clinical director for maternity, reiterated the importance of identifying women at risk early in their pregnancies. He assured that maternity teams have access to clinical guidance aimed at recognising warning signs and facilitating referrals to specialist centres equipped to handle such complexities.
Why it Matters
The risks associated with placenta accreta spectrum highlight a critical gap in our healthcare system that requires urgent attention. As more stories of near-tragedy emerge, the call for enhanced training and screening protocols becomes increasingly vital. Addressing these deficiencies not only safeguards the health of mothers but also ensures a safer environment for newborns. The stakes are high; proactive measures could significantly reduce the trauma and life-threatening complications faced by countless women during one of the most vulnerable times of their lives.
